State Key Laboratory of Diagnosis and Treatment of Infectious Diseases

Stem cell–based approaches in hepatitis B virus–related liver disease: therapeutic potential and advances in human-derived research models

Persistent hepatitis B virus (HBV) infection is a major cause of chronic hepatitis, liver fibrosis, cirrhosis, HBV-related acute-on-chronic liver failure (ACLF), and hepatocellular carcinoma. Although nucleos(t)ide analogues and pegylated interferon alfa suppress viral replicatio...

PI3K/AKT signaling pathway: molecular crossroads in tumorigenesis and therapeutic innovation

The PI3K/AKT signaling pathway serves as a pivotal regulatory hub that governs essential cellular processes, including growth, proliferation, metabolism, survival, and migration. In the context of tumorigenesis and cancer development, aberrant activation of this pathway drives ma...

HBV re-activation is associated with increased mortality and dysregulation of oxidative and polyamine metabolism in pre-acute-on-chronic liver failure

Abstract Background/Aims Acute-on-chronic liver failure (ACLF) is one of the deadliest complications of chronic liver disease yet treatment options are sparse. In Asia, HBV-reactivation (HBVr) is one of the most common triggers. Recently, HBV-associated ACLF was associated with d...

Functional mapping of IFITM3 resolves its antiviral core and deciphers human influenza susceptibility

Genetic variation in interferon-induced transmembrane protein 3 (IFITM3) contributes to inter-individual differences in influenza outcome, yet a comprehensive functional map of IFITM3 variation remains unavailable. Here we show a high-resolution functional atlas of 2,898 IFITM3 v...